To a degree, yes. I have posted that I believe that EDE can progress despite what I believe is poor management decisions. The move into Korea is the key that will start some sales and maybe encourage a move towards Australian sales. Unless there is news that the trials in the USA are failing then it does show there is a saleable product. I have never liked the company structure and I am not alone on that point. I have not criticised the product.
Management is not dumb. They just haven't been good managers in my eyes. They have had a wake up call.
To a degree, yes. I have posted that I believe that EDE can...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EDE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.216M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.2¢ | $8 | 3.965K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 63 | 125568442 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 21203859 | 29 |
View Market Depth
| Last trade - 10.02am 27/09/2024 (20 minute delay) ? |
| EDE (ASX) Chart |